LobbyingNervgen Pharma lobbying by quarter
Nervgen Pharma NGEN's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Defense and Health Issues.
Nervgen PharmaNGEN
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Defense$100K · 6 reports
- Health issues$60K · 4 reports
- Veterans$60K · 4 reports
- Budget and appropriations$40K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Defense, Dept of (DOD)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Cornerstone Government Affairs | $280K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SUSAN SWEAT | LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/10for Q2 | Cornerstone Government Affairs | $50K |
| 04/08for Q1 | Cornerstone Government Affairs | $50K |
| 01/07for Q4 2025 | Cornerstone Government Affairs | $50K |
| 25/10/14for Q3 2025 | Cornerstone Government Affairs | $30K |
| 25/09/22for Q3 2025 | Cornerstone Government Affairs | Under $5,000 |
| 23/07/19for Q2 2023 | Cornerstone Government Affairs | $20K |
| 23/04/15for Q1 2023 | Cornerstone Government Affairs | $50K |
| 23/01/20for Q4 2022 | Cornerstone Government Affairs | $30K |